Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm
Introduction
Hepatitis C virus (HCV) is a leading cause of liver-related morbidity
and mortality worldwide, especially in Mediterranean
countries where prevalence rates range from 1 to 3% in the
general population [1]. In Spain, the latest population-based data
collected during 2016 estimated anti-HCV and viremic (HCVRNA
detectable) prevalences lower than expected (1.2 and 0.4%,
respectively) [2, 3].
Voltar atrás
